ACL
AUCLINICAL FPO [ACL]
Healthcare · ASX Small Cap
$2.2400 -0.9%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score -2First seen: 2026-02-25
Score Breakdown
Technical57
Catalyst64
Sentiment50
Fundamental66
Momentum49
Risk Gate33
Active Signals
Bullish Signals
- RSI approaching oversold
- Volatility contracting (breakout setup)
- Cash positive / operating cashflow positive
- Low P/S ratio (0.6x)
- EPS estimates revised upward (+10pts)
- Near 52-week low (14% of range)
- Substantial holder(s) ceased (1)
- Elevated short interest (5.6%)
- Earnings in sharp decline (-52% QoQ)
- CANSLIM I: Institutional ownership (77%)
- Analyst EPS expectations rising (+32%)
- Altman Z-Score in grey zone (2.32)
- Days to cover very high (10.7)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Below 200-day MA (long-term downtrend)
- Post-earnings drift: negative surprise (SUE -10)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Update - Notification of buy-back - ACL
NONE Notification of cessation of securities - ACL
NONE Update - Notification of buy-back - ACL
HIGH Ceasing to be a substantial holder
Recent ASX Announcements
| 2026-03-01 | Update - Notification of buy-back - ACL |
| 2026-02-27 | Notification of cessation of securities - ACL |
| 2026-02-26 | Update - Notification of buy-back - ACL |
| 2026-02-25 | Ceasing to be a substantial holder |
| 2026-02-24 | Update - Notification of buy-back - ACL |
Key Metrics
$428.6M
Market Cap
1.0M
Avg Volume
0.7x
Vol Ratio
$2.08 — $3.24
52-Week Range
5.6%
Short Interest
N/A
Cash Runway
16.7%
ROE
3.6%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: -52% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 91% |
| L | Leader vs Laggard | laggard | RS: -4 |
| I | Institutional Sponsorship | pass | Inst: 77% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #47 of 119 · Sector avg: 51
View all Healthcare signals →